天天操夜夜操,一超碰,亚洲AV片在线观看,亚洲骚国产精品中文

歡迎蒞臨南京沃博生物科技有限公司官方網(wǎng)站!

Flecainide acetate 醋酸氟卡尼

貨號(hào) IIC1609 售價(jià)(元) 918
規(guī)格 10mg CAS號(hào) 54143-56-5
  • 產(chǎn)品簡(jiǎn)介
  • 相關(guān)產(chǎn)品

貨號(hào)

名稱

規(guī)格

價(jià)格

IIC1609-0010MG

Flecainide acetate

10MG

918

IIC1609-0025MG

Flecainide acetate

25MG

1920

產(chǎn)品簡(jiǎn)介:

Flecainide acetate是非選擇性Na (+)通道阻滯劑,是1C類(lèi)抗心律失常藥,尤其用于治療室上性心律失常。Flecainide acetate已被廣泛用于提供長(zhǎng)期竇性心律(SR)恢復(fù)以及減少房顫癥狀。 Flecainide acetate抑制心臟Nav1.5鈉通道,導(dǎo)致心臟動(dòng)作電位延長(zhǎng)。Flecainide acetate可降低完整大鼠心肌細(xì)胞的鈣火花、鈣波頻率和鈣波速度。此外,氟卡胺還顯示出在I(Na)活躍時(shí)減少Ca(2+)波。已經(jīng)證明氟卡胺可以顯著增加Na(+)/Ca(2+)-交換劑(NCX)介導(dǎo)的Ca(2+)外排[1]。

據(jù)報(bào)道,氟卡胺可延長(zhǎng)心室復(fù)極,對(duì)左心室心外膜的作用強(qiáng)于右心室心外膜。發(fā)現(xiàn)氟卡胺在心內(nèi)膜比心外膜產(chǎn)生更大的有效不應(yīng)期(ERP)延長(zhǎng),導(dǎo)致跨室壁的ERP離散度顯著增加[2]。 氟卡胺已顯示出劑量依賴性地降低全身壓力(0.8 μg/mL時(shí)為32%)和外周血管阻力(0.8 μg/mL時(shí)為15%)。此外,在大鼠后肢灌注模型中,在治療血漿濃度下,0.8 μg/mL的氟卡胺顯著降低心率(55次/分鐘)并增加QRS間期(9.9毫秒)[3]。

產(chǎn)品性質(zhì):

Cas No.:54143-56-5

別名:氟卡胺; R-818

化學(xué)名:acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide

Canonical SMILES:CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F

分子式:C19H24F6N2O5

分子量:474.39

溶解度:≥ 47.4mg/mL in DMSO, ≥ 47.4mg/mL in EtOH, ≥ 23.7mg/mL in Water with ultrasonic and warming儲(chǔ)存條件:Store at -20°C

注意事項(xiàng):

為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。

References:

1.Sikkel MB1, Collins TP, Rowlands C, Shah M, O'Gara P, Williams AJ, Harding SE, Lyon AR, MacLeod KT. Flecainide reduces Ca(2+) spark and wave frequency via inhibition of the sarcolemmal sodium current. Cardiovasc Res. 2013 May 1;98(2):286-96. doi: 10.1093/cvr/cvt012. Epub 2013 Jan 19.

2.Osadchii OE.Flecainide-induced proarrhythmia is attributed to abnormal changes in repolarization and refractoriness in perfused guinea-pig heart. J Cardiovasc Pharmacol. 2012 Nov;60(5):456-66. doi: 10.1097/FJC.0b013e31826b86cf.

3.Allison B1, Yang Y, Pourrier M, Gibson JK. Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model. J Cardiovasc Pharmacol. 2011 Apr;57(4):463-8. doi: 10.1097/FJC.0b013e318210276b.